Two investigators (HW and TG) independently performed the data extraction from each publication using a standardized form: publication data, baseline characteristics of the study population (sample size, sex, age, body mass index (BMI), body weight, abdominal circumference, waist-to-hip ratio, visceral adipose tissue (measured by computed tomography, magnetic resonance imaging, or dual-emission X-ray absorptiometry)), duration of follow-up, weight change during treatment and after treatment discontinuation, description of the weight management group and control group
Preclinical Studies : Animal studies and preclinical research demonstrating the effectiveness of PYY analogs provide foundational evidence that supports potential therapeutic effects in humans
Results confirmed positive impact of GLP-1 receptor agonists on MACE outcomes in patients with T2D but also revealed promising trends regarding heart failure outcomes in terms of reduced rate of heart failure-related events ( In conclusion, GLP-1 receptor agonists show potential in heart failure management through their multiple mechanisms of action, including direct cardioprotective effects, vasodilation, natriuresis, and glucose and weight control
Step therapy is a strategy where you try other less expensive medications first before Zepbound
Semaglutide GLP-1 works by mimicking the GLP-1 hormone, which helps regulate hunger and promotes feelings of fullness, supporting long-term weight loss